The new cluster will assist regulators in harmonizing their efforts to keep medicines safe, according to FDA.

FDA and EU Agency Launch Medicine Safety Cluster

The two agencies are holding monthly teleconferences about pharmacovigilance issues, and Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency are participating as observers.

The U.S. Food and Drug Administration announced Feb. 19 that is has expanded its collaboration with the European Medicines Agency by setting up a cluster on medicine safety (pharmacovigilance) topics, including biosimilars -- biological products that are highly similar to already approved biological products; the Affordable Care Act established an abbreviated approval pathway for them -- along with medicines to treat cancer, orphan medicines, medicines for children, and blood-based products. The two agencies are holding monthly teleconferences about these and other issues.

Clusters are regular meetings between EMA, which is a European Union agency based in London, and regulators outside the European Union. They focus on specific topic areas that have been identified as requiring an intensified exchange of information and collaboration, according to FDA's announcement. "Building on the experience of previous regular videoconferences between the FDA and the EMA in this area and on the recent creation of the EMA's Pharmacovigilance Risk Assessment Committee, this cluster will provide a forum for a more systematic and focused exchange of information on the safety of medicines," it states.

Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency are participating in the pharmacovigilance cluster as observers. "The work of protecting the health and safety of the American people cannot be done in isolation," said Dr. Janet Woodcock, director of FDA's Center for Drug Evaluation and Research. "It is part of a larger collaborative global effort between the FDA and its international regulatory partners to ensure the health and safety of all our citizens."

The new cluster will assist regulators in harmonizing their efforts to keep medicines safe, according to FDA, which noted that the information exchange "is covered by confidentiality arrangements between the FDA and the other participants."

Product Showcase

  • NoiseCHEK Personal Noise Dosimeter

    SKC NoiseCHEK is the easiest-to-use dosimeter available! Designed specifically for OEHS professionals, SKC NoiseCHEK offers the easiest operation and accurate noise measurements. Everything you need is right in your palm. Pair Bluetooth models to your mobile devices and monitor workers remotely with the SmartWave dB app without interrupting workflow. Careful design features like a locking windscreen, sturdy clip, large front-lit display, bright status LEDs, and more make NoiseCHEK the top choice in noise dosimeters. Demo NoiseCHEK at AIHA Connect Booth 1003. 3

  • Safety Shower Test Cart

    The Safety Shower Test Cart speeds up and simplifies emergency shower tests, ensures you stay in compliance with OSHA regulations, and significantly reduces testing costs. With 7 unique features, the cart makes testing easy, effective, and efficient. You can test water clarity, flow, temperature, and spread—all at the same time! Most safety shower testing kits create a mess, take too much time to use, and don't fully help you stay in compliance with OSHA & ANSI standards. Transform the way you test emergency showers with Green Gobbler Safety. 3

  • AirChek Connect Sampling Pump

    Stay connected to your sampling with the SKC AirChek® Connect Sampling Pump! With its Bluetooth connection to PC and mobile devices, you can monitor AirChek Connect pump operation without disrupting workflow. SKC designed AirChek Connect specifically for all OEHS professionals to ensure accurate, reliable flows from 5 to 5000 ml/min and extreme ease of use. AirChek Connect offers easy touch screen operation and flexibility. It is quality built to serve you and the workers you protect. Ask about special pricing and a demo at AIHA Connect Booth 1003. 3

Featured

Webinars